Northeast Pharmaceutical Group Co., Ltd.

Equities

000597

CNE0000009G0

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
4.61 CNY -1.07% Intraday chart for Northeast Pharmaceutical Group Co., Ltd. -3.15% -13.83%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Northeast Pharmaceutical Group Co., Ltd. Proposes Profit Distribution for 2023 CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Northeast Pharmaceutical's Levocarnitine Gets Nod to Enter EU Market MT
Northeast Pharmaceutical's Piracetam Passes Generic Drug Evaluation in China MT
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Northeast Pharmaceutical to Set Up Joint Venture With Muscat Changming Investments in Oman MT
Northeast Pharmaceutical Group Co., Ltd.(XSEC:000597) added to S&P Global BMI Index CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Northeast Pharmaceutical Group Co., Ltd. Announces 2022 Final Cash Profit Distribution Plan, Payable on 16 May 2023 CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Northeast Pharmaceutical Group Co., Ltd. Approves Final Cash Dividend for 2022 CI
Northeast Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for 2022 CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Northeast Pharma Appoints Former Bank Auditor as CFO MT
Northeast Pharmaceutical Unit Registers Anti-Seizure Drug in China MT
Northeast Pharmaceutical’s Piracetam Tablets Gets Regulatory Approval MT
Northeast Pharmaceutical Gets Supplementary Drug Application Approval For Tinidazole Tablets MT
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Northeast Pharmaceutical's Levonorgestrel Gets Passing Evaluation MT
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Northeast Pharmaceutical Group Co., Ltd. Proposes Final Dividend for the Year 2021, Payable on 27 May 2022 CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Northeast Pharmaceutical Group Co., Ltd. Approves the Profit Distribution for 2021 CI
Northeast Pharmaceutical Group Co., Ltd. Proposes Cash Dividend for 2021 CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Chart Northeast Pharmaceutical Group Co., Ltd.
More charts
Northeast Pharmaceutical Group Co., Ltd. specializes in the production and marketing of pharmaceutical ingredients and preparations. The group's products include antibiotics, vitamins, cardiovascular treatments, anesthetics, medical plants, etc. China accounts for 86.3% of net sales.
More about the company
  1. Stock Market
  2. Equities
  3. 000597 Stock
  4. News Northeast Pharmaceutical Group Co., Ltd.
  5. Northeast Pharmaceutical : Jiangxi Fangda Steel to Raise Stake in Northeast Pharma to 58% For $418 Million, Triggering Tender Offer